Group One Trading, L.P. Taysha Gene Therapies, Inc. Transaction History

Group One Trading, L.P.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$1.33 - $2.88 $8,525 - $18,460	6,410 Added 114.02%	12,032 $21,000
Q3 2023 Nov 09, 2023	BUY	$0.63 - $3.66 $3,541 - $20,576	5,622 New	5,622 $17,000
Q1 2023 May 12, 2023	BUY	$0.65 - $2.3 $2,305 - $8,158	3,547 Added 798.87%	3,991 $3,000
Q4 2022 Feb 09, 2023	BUY	$1.39 - $2.98 $617 - $1,323	444 New	444 $1,000

117

136M

25.9K

24K

Ticker TSHA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,359,500
Market Cap $85.1M
Description
Taysha Gene Therapies, Inc., a gene therapy company, focuses on developing and commercializing adeno-associated virus-based gene therapies for the treatment of monogenic diseases of the central nervous system. It primarily develops TSHA-120 for the treatment of giant axonal neuropathy; TSHA-102 for the treatment of Rett syndrome; TSHA-121 for th...

Get notified when there are updates to the investment portfolio of Group One Trading, L.P., based on Form 13F filings with the SEC.

Stay updated on Group One Trading, L.P. with notifications on news.